1:49 Association Between Angiotensin Blockade and Response to PD-1/L1 Inhibition in Metastatic Urothelial Carcinoma Oncology @sonpavde, of @DanaFarber_GU, discusses the effects of #angiotensin blockade on #PD-1/L1 inhibition in #metastatic #urothelialcarcinoma.
5:48 Therapeutic Effects of WST11 Vascular-Targeted Photodynamic Therapy Urology @lucasmnnogueira, of @sloan_kettering, discusses the #safety and #efficacy of WST11 vascular-targeted #photodynamic therapy.
1:26 Promising New Enzyme Replacement Therapy for Late-Onset Pompe Disease Pompe Disease Content Hub Priya Kishnani, MD, from @DukeMedSchool, discusses the use of #avalglucosidase alfa in late-onset #PompeDisease.
5:15 Safety and Efficacy of New Enzyme Replacement Therapy for Pompe Disease Pompe Disease Content Hub @HaniKushlaf, of @UCNeuroPMR, discusses the #safety and #efficacy of #avalglucosidase alfa in #PompeDisease.
2:15 Newborn Screening: Communication With Parents Pompe Disease Content Hub Dawn Laney, MS, CGC, CCRC, of the Emory Genetic Clinical Trials Center, discusses #communication with parents regarding #newbornscreening.
7:23 Outcomes of Patients With Multiple Myeloma and COVID-19 Multiple Myeloma Content Hub Nikhil Munshi, MD, of @danafarber and @harvardmed discusses management and outcomes of patients with #multiplemyeloma and #COVID19.
4:21 Monitoring Responses in Patients With Late-Stage Multiple Myeloma Multiple Myeloma Content Hub Heinz Ludwig, MD, from Wilhelminen Cancer Research Institute, discusses #monitoring responses in late-stage #multiplemyeloma.
4:29 Use of Aducanumab for Treatment of Alzheimer’s Disease Neurology Charles Bernick, MD, MPH, of @MemoryBrain_UW, discusses #aducanumab and its use for slowing #Alzheimer #progression.
23:03 Diagnostic Principles for TP53-Mutant AML AML Content Hub @JoeKhouryMD of @MDAndersonNews discusses #diagnosis of #AML with TP53 #mutations.
4:00 Patch Testing for Contact Dermatitis Allergy / Immunology Rachel L. Schreiber, MD, from @TeamAllergy discusses #patchtesting for #contactdermatitis.
